Growth hormone and somatostatin interaction in the ulcerogenic effect of cysteamine in female rats

Journal of Physiology Paris

Volumn 91, Issue 3-5, 1997, Pages 127-130

  Drago, F ^a   Montoneri, C ^a  

^a UNIVERSITY OF CATANIA   (Italy)

Author keywords

Cysteamine; Gastric lesions; GH; SRIH

Indexed keywords

GROWTH HORMONE; MERCAPTAMINE; SOMATOSTATIN;

ANIMAL EXPERIMENT; CONFERENCE PAPER; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFECT; FEMALE; INCIDENCE; NONHUMAN; RAT; STOMACH MUCOSA LESION; SUBCUTANEOUS DRUG ADMINISTRATION; ULCEROGENESIS;

EID: 0030690112     PISSN: 09284257     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0928-4257(97)89476-4     Document Type: Conference Paper

References (20)

1. Arai I, Hirose Kijima H, Ito Usuki C, Otomo S (1991) Putative role of endogenous insulin in cysteamine-induced hypersecretion of gastric acid in rats. Eur J Pharmacol 202, 213-219
2. Bernardini MC, Blandizzi C, Morini G, Chiavarini M, Impicciatore M, Del Tacca (1989) Pirenzepine prevents cysteamine-induced formation of gastroduodenal ulcers and reduction of mesenteric circulation. Arch Int Pharmacodyn 302, 242-254
3. Bertherat J, Bluet-Pajot MT, Epelbaum J (1995) Neuroendocrine regulation of growth hormone. Eur J Endocrinol 132, 12-24
4. Bloom SR, Mortimer CM, Thorner MO (1974) Inhibition of gastrin and gastric acid secretion by growth-hormone release-inhibiting hormone. Lancet, ii, 1106-1109
5. Groves WG, Schlossen JH, Mead FD (1974) Acid hypersecretion and duodenal ulcers produced by cysteamine in rats. Res Commun Chem Pathol Pharmacol, 9, 523-534
6. Hayes JR, Johnson DG, D. Koerker D, Williams RH (1975) Inhibition of gastrin release by somatostatin in vitro. Endocrinology 96, 1374-1376
7. Hoyer D, Lubbert H, Bruns C (1994) Molecular pharmacology of somatostatin receptors. Naunyn-Schmiedeberg Arch Pharmacol, 350, 441-453
8. Kim KH, Kim HY, Lee GY, Hong SS (1985) Involvement of histamine release in the mechanism of cysteamine-induced gastric acid hypersecretion. Arch Int Pharmacodyn 276, 279-286
9. Konturek SJK, Brzozowski T, Dembinski A, Warzecha Z, Konturek PK, Yanaihara N (1988) Interaction of growth hormone-releasing factor and somatostatin on ulcer healing and mucosal growth in rats: role of gastrin and epidermal growth factor. Digestion, 41 121-128
10. Kurebayashi Y, Asano M, Hashizume T, Akashi A (1985) Changes in duodenal mucosal blood flow and mucus glycoprotection content during cysteamine-induced duodenal ulceration in rats. Arch Int Pharmacodyn 276, 152-162
11. Lehy T, Accary JP, Dubrasquet MD, Lewin MJM (1986) Growth hormone-releasing factor (somatocrinin) stimulates epithelial cell proliferation in the rat digestive tract. Gastroenterology 90, 646-653
12. McIntosh C, Backich V, Trotter T, Kwok YN, Nishimura E, Pederson R, Brown J (1984) Effect of cysteamine on secretion of gastrin and somatostatin from the rat stomach. Gastroenterology 96, 834-838
13. Szabo S, Reichlin S (1980) Multi-organ depletion of somatostatin caused by the duodenal ulcerogen cysteamine. Regul Pept 1, suppl 1 S-111
14. Szabo S, Reichlin S (1981) Somatostatin in rat tissues is depleted by cysteamine administration. Endocrinology 109, 2255-2257
15. Szabo S, Reichlin S (1983) Somatostatin depletion of the gut and pacreas induced by cysteamine is not prevented by vagotomoty or by dopaminc agonists. Regul Pept 6, 43-49
16. Szabo S, Reichlin S (1985) Somatostatin depletion by cysteamine: mechanism and implication for duodenal ulceration. Fed Proc 44, 2540-2545
17. Szabo S, Reynolds ES, Lightenberger LM, Dzan VJ (1976) Pathogenesis of duodenal ulcer. Gastric hyperacidity caused by propionitrile and cysteamine in rats. Res Commun Chem Pathol Pharmacol 16, 311-322
18. Szabo S, Haith LR, Reynolds ES (1979) Pathogenesis of duodenal ulceration produced by cysteamine or propionitrile. Influence of vagotomy, sympathectomy, histamine depletion and hormones. Dig Dis Sci 24, 471-477
19. Szabo S, Horner HC, Maull H, Schnoor J, Chiueh CC, Palkovits M (1987) Biochemical changes in tissue catecholamines and serotonin in duodenal ulceration caused by cysteamine and propionitrile in the rat. J Pharmacol Exp Ther 240, 871-878
20. Tannenbaum GS, McCarthy GF, Zeitler P, Beaudet A (1990) Cysteamine-induced enhancement of growth hormone-releasing factor (GRF) immunoreactivity in arcuate neurons: morphological evidence for putative somatostatin/GRF interactions within hypothalamus. Endocrinology 127, 2251-2560